Cita APA

Steenbrugge, J., Vander Elst, N., Demeyere, K., De Wever, O., Sanders, N. N., Van Den Broeck, W., . . . Meyer, E. (2021). OMO-1 reduces progression and enhances cisplatin efficacy in a 4T1-based non-c-MET addicted intraductal mouse model for triple-negative breast cancer. NPJ Breast Cancer.

Citación estilo Chicago

Steenbrugge, Jonas, Niels Vander Elst, Kristel Demeyere, Olivier De Wever, Niek N. Sanders, Wim Van Den Broeck, Eric Ciamporcero, Timothy Perera, y Evelyne Meyer. "OMO-1 Reduces Progression and Enhances Cisplatin Efficacy in a 4T1-based Non-c-MET Addicted Intraductal Mouse Model for Triple-negative Breast Cancer." NPJ Breast Cancer 2021.

Cita MLA

Steenbrugge, Jonas, et al. "OMO-1 Reduces Progression and Enhances Cisplatin Efficacy in a 4T1-based Non-c-MET Addicted Intraductal Mouse Model for Triple-negative Breast Cancer." NPJ Breast Cancer 2021.